Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>N-tert-Butylpiperidine-2-carboxamide is a small molecule that has been shown to bind to the cavity of the active site of human thiopurine S-methyltransferase (TPMT), blocking access by substrates and competitive inhibitors. It was synthesized as a peptidomimetic inhibitor for TPMT, which is an enzyme that catalyzes the methylation of thiopurines, such as 6-MP. The X-ray crystallographic studies revealed that N-tert-butylpiperidine-2-carboxamide is a homodimeric molecule with two binding sites on each monomer. The inhibition of TPMT by N-tert-butylpiperidine-2-carboxamide results in increased levels of 6MP and decreased levels of 6TG, leading to improved therapeutic outcomes when given with 6MP.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4H,5H-Imidazo[1,5-a]quinoxalin-4-one is a potent inhibitor of phosphodiesterase. It has been shown to bind to the active site of the enzyme and inhibit phosphodiesterase activity in vitro. The drug inhibits phosphodiesterase type 5 (PDE5) which is an enzyme that breaks down cyclic guanosine monophosphate (cGMP). This inhibition leads to increased levels of cGMP and can lead to dysfunction in some tissues.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-((1H-Pyrazol-1-yl)methyl)benzonitrile is a chemical compound that is used as an antidepressant in psychiatric patients. It has been shown to have a positive effect on the mood of patients with major depressive disorder and bipolar disorder, but does not have significant effects on the overall sleep patterns. The drug has also been shown to be effective against cancer, specifically colorectal cancer. This medication has a low energy profile and no serious adverse effects on the cardiovascular system.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-Chloro-5-methoxyquinazoline is a diazine that has been synthesized by the coupling of 2,4,6-trichlorobenzoyl chloride and 4-chloro-5-methoxyaniline. This compound is an example of a metallation reaction. The chloromethyl group on the chlorobenzene ring is replaced by a methyl group from the methoxy group on the aniline ring. Metallation reactions are very important in synthetic chemistry because they allow for the introduction of other functional groups into organic molecules.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-(3-Methoxypropyl)piperidin-4-amine is a synthetic drug with the chemical formula C10H21NO2. It is an oxime that has been used in medicine to treat poisoning by hydroxylamine and organic solvents. 1-(3-Methoxypropyl)piperidin-4-amine is an effective scavenger of the hydroxyl radical and has been shown to increase intestinal motility. The synthesis of this drug relies on the use of recycled materials, such as 5-hydroxytryptamine 4 (5HT4) receptor antagonists and industrial products, and can be carried out using environmentally friendly processes.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Methoxy-5-methylpyridin-3-amine is an alkaloid that can be synthesized by the cross-coupling of 2,5-dimethylpyridine and 3-aminopyridine. It is a precursor to the antibiotic streptonigrin, which has been shown to have bacteriostatic and bactericidal effects against Gram positive bacteria. This compound can also be used for the synthesis of analogues with different substituents at the 2 position or as a coupling partner in cross-coupling reactions. This compound also has potential applications in organic synthesis due to its ring system.</p>

<p>Versatile small molecule scaffold</p>

<p>4-Benzylpiperidin-2-one is a pyrrole compound that has been shown to have significant activity in the central nervous system. It acts as a potent antagonist of adenosine A1 receptor and is an agonist at dopamine D2 receptor. 4-Benzylpiperidin-2-one has been shown to be a potent inhibitor of naoac, which may be due to its ability to accommodate the benzyl group. This drug has also been shown to have pharmacokinetic properties that are favorable for oral administration.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>7-Ethyl-1-benzofuran-2-carbaldehyde is a chiral molecule that can be synthesized from two commercially available starting materials. This compound has been shown to provide an effective catalyst for the synthesis of chiral amines and alcohols, as well as other organic reactions. Asymmetric catalytic reactions are often difficult to achieve, but this compound provides a cost-effective solution.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>